全文获取类型
收费全文 | 724篇 |
免费 | 37篇 |
出版年
2021年 | 9篇 |
2019年 | 7篇 |
2018年 | 8篇 |
2017年 | 11篇 |
2016年 | 19篇 |
2015年 | 22篇 |
2014年 | 31篇 |
2013年 | 45篇 |
2012年 | 44篇 |
2011年 | 38篇 |
2010年 | 24篇 |
2009年 | 22篇 |
2008年 | 38篇 |
2007年 | 21篇 |
2006年 | 22篇 |
2005年 | 22篇 |
2004年 | 28篇 |
2003年 | 23篇 |
2002年 | 24篇 |
2000年 | 9篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 9篇 |
1996年 | 10篇 |
1995年 | 8篇 |
1994年 | 7篇 |
1988年 | 5篇 |
1982年 | 5篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1973年 | 10篇 |
1971年 | 6篇 |
1969年 | 4篇 |
1968年 | 6篇 |
1967年 | 4篇 |
1966年 | 6篇 |
1965年 | 4篇 |
1957年 | 5篇 |
1956年 | 4篇 |
1939年 | 4篇 |
1935年 | 4篇 |
1932年 | 5篇 |
1930年 | 8篇 |
1929年 | 8篇 |
1927年 | 6篇 |
1905年 | 4篇 |
1896年 | 11篇 |
1894年 | 6篇 |
1887年 | 5篇 |
1856年 | 4篇 |
排序方式: 共有761条查询结果,搜索用时 171 毫秒
111.
112.
113.
114.
115.
Bruno Studer Torben Asp Ursula Frei Stephan Hentrup Helena Meally Aurélie Guillard Susanne Barth Hilde Muylle Isabel Roldán-Ruiz Philippe Barre Carole Koning-Boucoiran Gerda Uenk-Stunnenberg Oene Dolstra Leif Skøt Kirsten P. Skøt Lesley B. Turner Mervyn O. Humphreys Roland Kölliker Niels Roulund Klaus K. Nielsen Thomas Lübberstedt 《Molecular breeding : new strategies in plant improvement》2008,21(4):533-548
An expressed sequence tag (EST) library of the key grassland species perennial ryegrass (Lolium perenne L.) has been exploited as a resource for microsatellite marker development. Out of 955 simple sequence repeat (SSR) containing
ESTs, 744 were used for primer design. Primer amplification was tested in eight genotypes of L. perenne and L. multiflorum representing (grand-) parents of four mapping populations and resulted in 464 successfully amplified EST-SSRs. Three hundred
and six primer pairs successfully amplified products in the mapping population VrnA derived from two of the eight genotypes
included in the original screening and revealed SSR polymorphisms for 143 ESTs. Here, we report on 464 EST-derived SSR primer
sequences of perennial ryegrass established in laboratory assays, providing a dedicated tool for marker assisted breeding
and comparative mapping within and among forage and turf grasses.
Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users. 相似文献
116.
In the autumn of 1995 the first outbreaks of enterohemorrhagic Escherichia coli O157:H7 including ca 100 human cases were reported in Sweden. From outbreaks in other countries it is known that cattle may carry these bacteria and in many cases is the source of infection. Therefore, the present study was performed to survey the Swedish bovine population for the presence of verotoxin-producing E. coli (VTEC) of serotype O157:H7. Individual faecal samples were collected at the 16 main Swedish abattoirs from April 1996 to August 1997. Of 3071 faecal samples, VTEC O157 were found in 37 samples indicating a prevalence of 1.2% (CI95% 0.8–1.6). All 37 isolates carried genes encoding for verotoxin (VT1 and/or VT2), intimin, EHEC-haemolysin and flagellin H7 as determined by PCR. Another 3 strains were of serotype O157:H7 but did not produce verotoxins. The 37 VTEC O157:H7 strains were further characterised by phage typing and pulsed-field gel electrophoresis. The results clearly show that VTEC O157:H7 is established in the Swedish bovine population and indicate that the prevalence of cattle carrying VTEC O157:H7 is correlated to the overall geographical distribution of cattle in Sweden. Results of this study have formed the basis for specific measures recommended to Swedish cattle farmers, and furthermore, a permanent monitoring programme was launched for VTEC O157:H7 in Swedish cattle at slaughter. 相似文献
117.
Jon Amund Kyte Sissel Trachsel Bente Risberg Per thor Straten Kari Lislerud Gustav Gaudernack 《Cancer immunology, immunotherapy : CII》2009,58(10):1609-1626
Cancer vaccine trials frequently report on immunological responses, without any clinical benefit. This paradox may reflect
the challenge of discriminating between effective and pointless immune responses and sparse knowledge on their long-term development.
Here, we have analyzed T cell responses in long-term survivors after peptide vaccination. There were three main study aims:
(1) to characterize the immune response in patients with a possible clinical benefit. (2) To analyze the long-term development
of responses and effects of booster vaccination. (3) To investigate whether the Th1/Th2-delineation applies to cancer vaccine
responses. T cell clones were generated from all nine patients studied. We find that surviving patients harbor durable tumor-specific
responses against vaccine antigens from telomerase, RAS or TGFβ receptor II. Analyses of consecutive samples suggest that
booster vaccination is required to induce robust T cell memory. The responses exhibit several features of possible clinical
advantage, including combined T-helper and cytotoxic functionality, recognition of naturally processed antigens and diverse
HLA-restriction and fine-specificity. CD4−CD8− T cell clones display unconventional cytotoxicity and specifically kill tumor cells expressing mutated TGFβ receptor II.
Cytokine profiling on the long-term survivors demonstrates high IFNγ/IL10-ratios, favoring immunity over tolerance, and secretion
of multiple chemokines likely to mobilize the innate and adaptive immune system. Interestingly, these pro-inflammatory cytokine
profiles do not follow a Th1/Th2-delineation. Most IFNγhigh/IL4low/IL10low cultures include high concentrations of hallmark Th2-cytokines IL-5 and IL-13. This does not reflect a mixture of Th1- and
Th2-clones, but applies to 19/20 T cell clones confirmed to be monoclonal through TCR clonotype mapping. The present study
identifies several factors that may promote clinical efficacy and suggests that cytokine profiling should not rely on the
Th1/Th2-paradigm, but assess the overall inflammatory milieu and the balance between key cytokines.
Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users. 相似文献
118.
Grantley R. Peck Jose A. Chavez William G. Roach Bogdan A. Budnik William S. Lane H?kan K. R. Karlsson Juleen R. Zierath Gustav E. Lienhard 《The Journal of biological chemistry》2009,284(44):30016-30023
Insulin stimulates the translocation of the glucose transporter GLUT4 from intracellular locations to the plasma membrane in adipose and muscle cells. Prior studies have shown that Akt phosphorylation of the Rab GTPase-activating protein, AS160 (160-kDa Akt substrate; also known as TBC1D4), triggers GLUT4 translocation, most likely by suppressing its Rab GTPase-activating protein activity. However, the regulation of a very similar protein, TBC1D1 (TBC domain family, member 1), which is mainly found in muscle, in insulin-stimulated GLUT4 translocation has been unclear. In the present study, we have identified likely Akt sites of insulin-stimulated phosphorylation of TBC1D1 in C2C12 myotubes. We show that a mutant of TBC1D1, in which several Akt sites have been converted to alanine, is considerably more inhibitory to insulin-stimulated GLUT4 translocation than wild-type TBC1D1. This result thus indicates that similar to AS160, Akt phosphorylation of TBC1D1 enables GLUT4 translocation. We also show that in addition to Akt activation, activation of the AMP-dependent protein kinase partially relieves the inhibition of GLUT4 translocation by TBC1D1. Finally, we show that the R125W variant of TBC1D1, which has been genetically associated with obesity, is equally inhibitory to insulin-stimulated GLUT4 translocation, as is wild-type TBC1D1, and that healthy and type 2 diabetic individuals express approximately the same level of TBC1D1 in biopsies of vastus lateralis muscle. In conclusion, phosphorylation of TBC1D1 is required for GLUT4 translocation. Thus, the regulation of TBC1D1 resembles that of its paralog, AS160.Insulin stimulates glucose transport into adipose and muscle cells by increasing the amount of the GLUT4 glucose transporter at the cell surface by a process termed GLUT4 translocation (1, 2). Unstimulated adipocytes and myotubes sequester GLUT4 in intracellular compartments. Insulin activates signaling cascades that lead to the trafficking of specialized GLUT4 vesicles to the cell membrane and fusion of the vesicles therewith. A key signaling pathway for GLUT4 translocation proceeds from the insulin receptor through the activation of the protein kinase Akt. One Akt substrate that connects signaling to GLUT4 trafficking is the Rab GTPase-activating protein (GAP)3 known as AS160. There is now considerable evidence for the following scheme (2, 3): under basal conditions, AS160 acts as a brake on GLUT4 translocation by maintaining one or more Rab proteins required for translocation in their inactive GDP state; in response to insulin, Akt phosphorylates AS160 and thereby suppresses its GAP activity; as a consequence, the elevation of the GTP form of the Rab proteins occurs, leading to the increased docking and subsequent fusion of the GLUT4 vesicles at the plasma membrane.More recently, we and others have characterized a paralog of AS160 known as TBC1D1 (4–7). Overall, TBC1D1 is 47% identical to AS160, with the GAP domain being 79% identical (4). Its GAP domain has the same Rab specificity as the GAP domain of AS160 (4). TBC1D1 is predominantly expressed in skeletal muscle; its expression in adipocytes is very low (5, 6). Nevertheless, 3T3-L1 adipocytes are a convenient cell type in which to examine the role of proteins in GLUT4 translocation, because insulin causes an ∼10-fold increase in GLUT4 at the cell surface. Previously, we examined the role of TBC1D1 in GLUT4 translocation by overexpressing it in 3T3-L1 adipocytes. Surprisingly, even though insulin led to phosphorylation of TBC1D1 on Akt site(s), ectopic TBC1D1 potently inhibited GLUT4 translocation (4, 5). By contrast, overexpression of AS160 did not inhibit GLUT4 translocation (8). This difference suggested that the regulation of TBC1D1 might be fundamentally different from that of AS160. In the present study, we show that this is not the case. By reducing the level of ectopic TBC1D1, we have obtained evidence that phosphorylation of TBC1D1 on several likely Akt sites relieves the inhibitory effect on GLUT4 translocation. In addition, we have examined the effect of a variant of TBC1D1 genetically associated with obesity on GLUT4 translocation and determined the relative levels of TBC1D1 in muscle biopsies from healthy and type 2 diabetic individuals. 相似文献
119.
120.